Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeroen W G Derksen

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 13, 2022
Systematic review and non-inferiority meta-analysis of randomised phase II/III trials on S-1-based therapy versus 5-fluorouracil- or capecitabine-based therapy in the treatment of patients with metastatic colorectal cancerJeroen W G Derksen, Karel C Smit, Anne M May, et al.
Journal of Cancer Survivorship : Research and Practice|November 27, 2023
Practice patterns, experiences, and challenges of German oncology health care staff with smoking cessation in patients with cancer: a cross-sectional survey studyFrederike Bokemeyer, Lisa Lebherz, Carsten Bokemeyer, et al.
International Journal of Cancer|June 3, 2022
Translation of IDEA trial results into clinical practice: Analysis of the implementation of a new guideline for colon cancerKarlijn L van Rooijen, Jeroen W G Derksen, Helena M Verkooijen, et al.
Cancer Epidemiology|December 11, 2024
The nationwide Dietary Intake after Diagnosis and Colorectal Cancer Outcomes (PLCRC-PROTECT) cohort: Study design, clinical characteristics and baseline health behaviorsJeroen W G Derksen, Karel C Smit, Irene W F Hoeven, et al.
Cancer Causes & Control : CCC|December 23, 2019
Case-control study of endogenous sex steroid hormones and risk of endometrial cancerChristine M Friedenreich, Jeroen W G Derksen, Thomas Speidel, et al.
European Journal of Cancer (Oxford, England : 1990)|July 19, 2018
Monitoring potentially modifiable lifestyle factors in cancer survivors: A narrative review on currently available methodologies and innovations for large-scale surveillanceJeroen W G Derksen, Sandra Beijer, Miriam Koopman, et al.
Clinical Nutrition ESPEN|July 12, 2024
Use of automated assessment for determining associations of low muscle mass and muscle loss with overall survival in patients with colorectal cancer - A validation studyKarel C Smit, Jeroen W G Derksen, Sophie A Kurk, et al.
JNCI Cancer Spectrum|July 31, 2019
Factors Contributing to Cancer-Related Muscle Wasting During First-Line Systemic Treatment for Metastatic Colorectal CancerJeroen W G Derksen, Sophie A Kurk, Marieke J Oskam, et al.
BMC Cancer|January 13, 2018
Effects of physical activity on colorectal cancer risk among family history and body mass index subgroups: a systematic review and meta-analysisEileen Shaw, Megan S Farris, Chelsea R Stone, et al.
JNCI Cancer Spectrum|August 10, 2021
Colorectal Cancer Care and Patients' Perceptions Before and During COVID-19: Implications for Subsequent SARS-CoV-2 Infection WavesJeroen W G Derksen, Anne M May, Lonneke V van de Poll-Franse, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
European Journal of Cancer (Oxford, England : 1990)|March 13, 2022
Systematic review and non-inferiority meta-analysis of randomised phase II/III trials on S-1-based therapy versus 5-fluorouracil- or capecitabine-based therapy in the treatment of patients with metastatic colorectal cancerJeroen W G Derksen, Karel C Smit, Anne M May, et al.
Journal of Cancer Survivorship : Research and Practice|November 27, 2023
Practice patterns, experiences, and challenges of German oncology health care staff with smoking cessation in patients with cancer: a cross-sectional survey studyFrederike Bokemeyer, Lisa Lebherz, Carsten Bokemeyer, et al.
International Journal of Cancer|June 3, 2022
Translation of IDEA trial results into clinical practice: Analysis of the implementation of a new guideline for colon cancerKarlijn L van Rooijen, Jeroen W G Derksen, Helena M Verkooijen, et al.
Cancer Epidemiology|December 11, 2024
The nationwide Dietary Intake after Diagnosis and Colorectal Cancer Outcomes (PLCRC-PROTECT) cohort: Study design, clinical characteristics and baseline health behaviorsJeroen W G Derksen, Karel C Smit, Irene W F Hoeven, et al.
Cancer Causes & Control : CCC|December 23, 2019
Case-control study of endogenous sex steroid hormones and risk of endometrial cancerChristine M Friedenreich, Jeroen W G Derksen, Thomas Speidel, et al.
European Journal of Cancer (Oxford, England : 1990)|July 19, 2018
Monitoring potentially modifiable lifestyle factors in cancer survivors: A narrative review on currently available methodologies and innovations for large-scale surveillanceJeroen W G Derksen, Sandra Beijer, Miriam Koopman, et al.
Clinical Nutrition ESPEN|July 12, 2024
Use of automated assessment for determining associations of low muscle mass and muscle loss with overall survival in patients with colorectal cancer - A validation studyKarel C Smit, Jeroen W G Derksen, Sophie A Kurk, et al.
JNCI Cancer Spectrum|July 31, 2019
Factors Contributing to Cancer-Related Muscle Wasting During First-Line Systemic Treatment for Metastatic Colorectal CancerJeroen W G Derksen, Sophie A Kurk, Marieke J Oskam, et al.
BMC Cancer|January 13, 2018
Effects of physical activity on colorectal cancer risk among family history and body mass index subgroups: a systematic review and meta-analysisEileen Shaw, Megan S Farris, Chelsea R Stone, et al.
JNCI Cancer Spectrum|August 10, 2021
Colorectal Cancer Care and Patients' Perceptions Before and During COVID-19: Implications for Subsequent SARS-CoV-2 Infection WavesJeroen W G Derksen, Anne M May, Lonneke V van de Poll-Franse, et al.
Pageof 4